| [1] | Bundhun PK, Kumari A, Huang F. Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: a systematic review and meta-analysis[J]. Medicine (Baltimore), 2017, 96: e8086. doi: 10.1097/MD.0000000000008086
 | 
																													
																						| [2] | Veiga CS, Coutinho DS, Nakaie CMA, et al. Subclinical pulmonary abnormalities in childhood-onset systemic lupus erythematosus patients[J]. Lupus, 2016, 25: 645-651. doi: 10.1177/0961203316629554
																																					pmid: 26849883
 | 
																													
																						| [3] | Torre O, Harari S. Pleural and pulmonary involvement in systemic lupus erythematosus[J]. Presse Medicale Paris Fr, 2011, 40 (1 Pt 2): e19-e29. | 
																													
																						| [4] | Carmier D, Marchand-Adam S, Diot P, et al. Respiratory involvement in systemic lupus erythematosus[J]. Rev Mal Respir, 2010, 27: e66-e78. | 
																													
																						| [5] | Cutolo M, Melsens K, Wijnant S, et al. Nailfold capillaroscopy in systemic lupus erythematosus: a systematic review and critical appraisal[J]. Autoimmun Rev, 2018, 17: 344-352. doi: S1568-9972(18)30031-4
																																					pmid: 29427827
 | 
																													
																						| [6] | Anuardo P, Verdier M, Gormezano NWS, et al. Subclinical pulmonary hypertension in childhood systemic lupus erythematosus associated with minor disease manifestations[J]. Pediatr Cardiol, 2017, 38: 234-239. doi: 10.1007/s00246-016-1504-6
																																					pmid: 27826712
 | 
																													
																						| [7] | Araujo DB, Borba EF, Silva CA, et al. Alveolar hemorrhage: distinct features of juvenile and adult onset systemic lupus erythematosus[J]. Lupus, 2012, 21: 872-877. doi: 10.1177/0961203312441047
																																					pmid: 22427319
 | 
																													
																						| [8] | Mira-Avendano IC, Abril A. Pulmonary manifestations of Sjögren syndrome, systemic lupus erythematosus, and mixed connective tissue disease[J]. Rheum Dis Clin North Am, 2015, 41: 263-277. doi: 10.1016/j.rdc.2015.01.001
 | 
																													
																						| [9] | Campos LMA, Kiss MH, D’Amico EA, et al. Anti-phospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus[J]. Lupus, 2003, 12: 820-826. pmid: 14667097
 | 
																													
																						| [10] | Nigrovic PA. Storm warning: lung disease in systemic juvenile idiopathic arthritis[J]. Arthritis Rheumatol Hoboken NJ, 2019, 71: 1773-1775. | 
																													
																						| [11] | Kelly CA, Saravanan V, Nisar M, et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study[J]. Rheumatol Oxf Engl, 2014, 53: 1676-1682. doi: 10.1093/rheumatology/keu165
 | 
																													
																						| [12] | Yunt ZX, Chung JH, Hobbs S, et al. High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: relationship to survival[J]. Respir Med, 2017, 126: 100-104. doi: S0954-6111(17)30099-9
																																					pmid: 28427540
 | 
																													
																						| [13] | Mohd Noor N, Mohd Shahrir MS, Shahid MS, et al. Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease[J]. Int J Rheum Dis, 2009, 12: 136-144. doi: 10.1111/j.1756-185X.2009.01376.x
																																					pmid: 20374331
 | 
																													
																						| [14] | Kimura Y, Weiss JE, Haroldson KL, et al. Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis[J]. Arthritis Care Res, 2013, 65: 745-752. doi: 10.1002/acr.21889
 | 
																													
																						| [15] | Saper VE, Chen G, Deutsch GH, et al. Emergent high fatality lung disease in systemic juvenile arthritis[J]. Ann Rheum Dis, 2019, 78: 1722-1731. doi: 10.1136/annrheumdis-2019-216040
																																					pmid: 31562126
 | 
																													
																						| [16] | Zisman DA, McCune WJ, Tino G, et al. Drug-induced pneumonitis: the role of methotrexate[J]. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG, 2001, 18: 243-252. | 
																													
																						| [17] | 侯俊, 闫淯淳, 苏改秀, 等. 抗黑色素瘤分化相关基因蛋白5抗体与幼年皮肌炎间质性肺病严重程度的关系[J]. 中华医学杂志, 2021, 101(33): 2606-2610. | 
																													
																						| [18] | Tashkin DP, Roth MD, Clements PJ, et al. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial[J]. Lancet Respir Med, 2016, 4: 708-719. doi: 10.1016/S2213-2600(16)30152-7
																																					pmid: 27469583
 | 
																													
																						| [19] | Robles-Perez A, Dorca J, Castellví I, et al. Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data[J]. Rheumatol Int, 2020, 40: 719-726. doi: 10.1007/s00296-020-04545-0
																																					pmid: 32157369
 | 
																													
																						| [20] | Kowal-Bielecka O, Fransen J, Avouac J, et al. Update of EULAR recommendations for the treatment of systemic sclerosis[J]. Ann Rheum Dis, 2017, 76: 1327-1339. doi: 10.1136/annrheumdis-2016-209909
																																					pmid: 27941129
 | 
																													
																						| [21] | Valeur NS, Stevens AM, Ferguson MR, et al. Multimodality thoracic imaging of juvenile systemic sclerosis: emphasis on clinical correlation and high-resolution CT of pulmonary fibrosis[J]. AJR Am J Roentgenol, 2015, 204: 408-422. doi: 10.2214/AJR.14.12461
 | 
																													
																						| [22] | Lin Y, Yi Q, Cheng D. Rapid progressive interstitial lung disease as initial manifestation of primary Sjögren’s syndrome: a case report[J]. Int J Clin Exp Med, 2014, 7: 5904-5908. | 
																													
																						| [23] | Burdt MA, Hoffman RW, Deutscher SL, et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings[J]. Arthritis Rheum, 1999, 42: 899-909. doi: 10.1002/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L
 | 
																													
																						| [24] | Hetlevik SO, Flatø B, Rygg M, et al. Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study[J]. Ann Rheum Dis, 2017, 76: 159-165. doi: 10.1136/annrheumdis-2017-eular.3226
 | 
																													
																						| [25] | Vegh J, Szodoray P, Kappelmayer J, et al. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension[J]. Scand J Immunol, 2006, 64: 69-76. pmid: 16784493
 |